Showing results (151-160 of 496) with videos related to

Sort By:
Pageof 50
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1995
Alpha-1-antichymotrypsin bi-allele polymorphism, apolipoprotein-E tri-allele polymorphism and genetic risk of Alzheimer's syndromeJ Thome, A Baumer, J Kornhuber, et al.
Journal of Neurochemistry|November 1, 1990
Normal mitochondrial genome in brain from patients with Parkinson's disease and complex I defectP Lestienne, J Nelson, P Riederer, et al.
European Journal of Pharmacology|April 25, 1991
Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain studyJ Kornhuber, J Bormann, M Hübers, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain. Short communicationM Mogi, M Harada, T Kondo, et al.
Infusionstherapie Und Klinische Ernahrung|February 1, 1985
[Changes in and modulation of receptor activity in hepatic encephalopathy]E Kienzl, P Riederer, T Brücke, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|January 2, 2001
Increased frequency of the alpha-1-antichymotrypsin T allele in cerebral amyloid angiopathyN Durany, R Ravid, P Riederer, et al.
Archives of Gerontology and Geriatrics|June 8, 2001
Alpha-lipoic acid as a new treatment option for Alzheimer [corrected] type dementiaK Hager, A Marahrens, M Kenklies, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 28, 2003
Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorderS Yamada, M Yamamoto, H Ozawa, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1995
Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's diseaseM Mogi, M Harada, T Kondo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 1, 1990
Adrenergic-cholinergic imbalances: the physostigmine-syndrome is not antagonized by the MAO-A inhibitor brofaromineJ Fritze, E Sofic, H Pfüller, et al.
Pageof 50